Literature DB >> 8704106

A low-affinity vasopressin V2-receptor gene in a kindred with X-linked nephrogenic diabetes insipidus.

K Yokoyama1, A Yamauchi, M Izumi, T Itoh, A Ando, E Imai, T Kamada, N Ueda.   

Abstract

In this study, a mutation in vasopressin Type 2 receptor (V2R) in a patient with hereditary nephrogenic diabetes insipidus (NDI) has been identified and characterized. The sequencing of the V2R gene from the patient revealed that there was a missense mutation (TAT to TGT) resulting in the substitution of 205Tyr for Cys in the putative third extracellular domain. The expression analysis in COS cells showed that the binding affinity of the mutant receptor (KD = 19.8 nM) for arginine vasopressin was much lower than that of the wild-type receptor (KD = 1.8 nM) so that intracellular cAMP production stimulated by arginine vasopressin was impaired in cells with the mutant V2R. From these results, it was concluded that the single amino-acid substitution of V2R is responsible for this familial disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8704106     DOI: 10.1681/ASN.V73410

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  4 in total

1.  A case of nephrogenic diabetes insipidus with a novel missense mutation in the AVPR2 gene.

Authors:  Akira Ashida; Daisuke Yamamoto; Hyogo Nakakura; Hideki Matsumura; Shinichi Uchida; Sei Sasaki; Hiroshi Tamai
Journal:  Pediatr Nephrol       Date:  2007-01-10       Impact factor: 3.714

2.  A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity.

Authors:  Marta Sanchez-Soto; Ravi Kumar Verma; Blair K A Willette; Elizabeth C Gonye; Annah M Moore; Amy E Moritz; Comfort A Boateng; Hideaki Yano; R Benjamin Free; Lei Shi; David R Sibley
Journal:  Sci Signal       Date:  2020-02-04       Impact factor: 8.192

3.  High-throughput screen for pharmacoperones of the vasopressin type 2 receptor.

Authors:  P Michael Conn; Emery Smith; Peter Hodder; Jo Ann Janovick; David C Smithson
Journal:  J Biomol Screen       Date:  2013-05-02

4.  How genetic errors in GPCRs affect their function: Possible therapeutic strategies.

Authors:  Henriette Stoy; Vsevolod V Gurevich
Journal:  Genes Dis       Date:  2015-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.